Found 65 clinical trials
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
Welcome to TogetherA study for memory loss If you are concerned about changes to your memory, joining the Together clinical study might be a suitable option for you. To qualify for this study, you must:· Be between 50 and 80 years old· Have mild memory problems or early Alzheimer’s disease· Meet some additional study criteria The …
- 99 views
- 22 Sep, 2022
- 86 locations
Care Partner Assisted Intervention to Improve Oral Health of Individuals With Mild Dementia
Care Partner Assisted Intervention to Improve Oral Health for Individuals with Mild Dementia is a randomized control trial (RCT) based in New York City and North Carolina. The intervention
- 0 views
- 09 Feb, 2023
- 2 locations
![A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Gantenerumab in Patients with Early [Prodromal to Mild] Alzheimer's Disease](/media/imagery/227902.svg)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Gantenerumab in Patients with Early [Prodromal to Mild] Alzheimer's Disease
Studies the effect of a new drug in Early Alzheimer's
- 34 views
- 08 Dec, 2020
- 1 location
A PATIENT- AND INVESTIGATOR-BLIND, PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BEPRANEMAB (UCB0107) IN STUDY PARTICIPANTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE (AD), FOLLOWED BY AN OPENLABEL EXTENSION PERIOD
Bepranemab (UCB0107) is being developed with the aim of blocking or reducing the cell-to-cell spread of tau pathology in patients with tau-mediated diseases, such as AD. To date, single ascending doses of bepranemab (up to 120mg/kg) have been evaluated in healthy study participants in two Phase 1 studies and no …
- 14 views
- 24 Jun, 2022
- 1 location
Mild Dementia/Alzheimer's Disease
Mild Dementia/Alzheimer's Disease
- 474 views
- 25 Mar, 2021
- 1 location
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
ADvance II: A 12-month Double-blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease
- 3 views
- 22 Nov, 2021
- 12 locations
Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of Piromelatine in Patients With Mild Dementia Due to Alzheimer's Disease.
Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of Piromelatine in Patients With Mild Dementia Due to Alzheimer's Disease.
- 104 views
- 08 Dec, 2020
- 1 location
- 87 views
- 25 Mar, 2021
- 1 location
The MGH Interdisciplinary Brain Center (IBC) Game Pack: A Panel of Digital Games for Tracking Cognitive Functioning in Adults with Subjective Cognitive Complaints, Mild Cognitive Impairment, or Mild Dementia
people with cognitive decline, mild dementia, and Alzheimer's Disease. We believe that by capturing data about a person’s daily performance on these games can help us better understand cognitive
- 2 views
- 08 Mar, 2023
- 1 location
An AI-based Method to Assess and Monitor the Cognitive Functions of Persons with Dementia
This pilot study will be investigating the feasibility of developing an AI solution to assess and monitor the progression of mild Alzheimer's dementia through automated speech and dialogue
- 20 views
- 22 Aug, 2022
- 1 location